759 related articles for article (PubMed ID: 11840146)
81. Molecular studies of chimerism and minimal residual disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation.
Elmaagacli AH; Beelen DW; Becks HW; Mobascher A; Stockova J; Trzensky S; Opalka B; Schaefer UW
Bone Marrow Transplant; 1996 Aug; 18(2):397-403. PubMed ID: 8864452
[TBL] [Abstract][Full Text] [Related]
82. Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions.
Porter DL; Collins RH; Shpilberg O; Drobyski WR; Connors JM; Sproles A; Antin JH
Biol Blood Marrow Transplant; 1999; 5(4):253-61. PubMed ID: 10465105
[TBL] [Abstract][Full Text] [Related]
83. Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation.
Spinelli O; Giussani U; Borleri G; Lazzari M; Michelato A; Dotti G; Barbui T; Rambaldi A
Haematologica; 2000 Nov; 85(11):1153-7. PubMed ID: 11064467
[TBL] [Abstract][Full Text] [Related]
84. Prophylactic impact of imatinib administration after allogeneic stem cell transplantation on the incidence and severity of chronic graft versus host disease in patients with Philadelphia chromosome-positive leukemia.
Nakasone H; Kanda Y; Takasaki H; Nakaseko C; Sakura T; Fujisawa S; Yokota A; Yano S; Usuki K; Maruta A; Abe D; Hoshino T; Takahashi S; Kanamori H; Okamoto S;
Leukemia; 2010 Jun; 24(6):1236-9. PubMed ID: 20428195
[No Abstract] [Full Text] [Related]
85. Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia.
Asnafi V; Rubio MT; Delabesse E; Villar E; Davi F; Damaj G; Hirsch I; Dhédin N; Vernant JP; Varet B; Buzyn A; Macintyre E
Leukemia; 2006 May; 20(5):793-9. PubMed ID: 16541140
[TBL] [Abstract][Full Text] [Related]
86. [Blast crisis of chronic myelocytic leukemia that was difficult to differentiate from Ph+ acute lymphoblastic leukemia].
Kaneko J; Uchiyama T; Oyake T; Enomoto S; Ono Y; Sugawara T; Numaoka H; Shimosegawa K; Itoh S; Murai K; Ishida Y; Kuriya S
Rinsho Ketsueki; 1999 Nov; 40(11):1174-80. PubMed ID: 10624128
[TBL] [Abstract][Full Text] [Related]
87. Relapse after allogeneic BMT for chronic myeloid leukemia (CML) may be sustained by a small number of leukemic 'stem cells': a hypothesis.
Frassoni F; Podestà M; Piaggio G; Pitto A; Figari O; Soracco M; Lint M; Fugazza G; Sessarego M; Bacigalupo A
Bone Marrow Transplant; 1999 Sep; 24(6):689-91. PubMed ID: 10490738
[TBL] [Abstract][Full Text] [Related]
88. [Leukocyte transfusion as therapy of recurrent CML after allogenic bone marrow transplantation].
Wiesneth M; Hertenstein B; Bunjes D; Novotny J; Stefanic M; Heinze B; Schreiner T; Kubanek B; Heimpel H; Arnold R
Beitr Infusionsther Transfusionsmed; 1994; 32():276-80. PubMed ID: 9480108
[TBL] [Abstract][Full Text] [Related]
89. A Philadelphia chromosome positive acute lymphoblastic leukemia of donor origin after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase.
Saito Y; Uzuka Y; Sakai N; Suzuki S; Toyota T
Bone Marrow Transplant; 2000 Jun; 25(11):1209-11. PubMed ID: 10849535
[TBL] [Abstract][Full Text] [Related]
90. Quantification of residual disease in Philadelphia-positive acute lymphoblastic leukemia: comparison of blood and bone marrow.
van Rhee F; Marks DI; Lin F; Szydlo RM; Hochhaus A; Treleaven J; Delord C; Cross NC; Goldman JM
Leukemia; 1995 Feb; 9(2):329-35. PubMed ID: 7869772
[TBL] [Abstract][Full Text] [Related]
91. Molecular remission occurring after donor leukocyte infusions for the treatment of relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation.
Drobyski WR; Roth MS; Thibodeau SN; Gottschall JL
Bone Marrow Transplant; 1992 Sep; 10(3):301-4. PubMed ID: 1422483
[TBL] [Abstract][Full Text] [Related]
92. Donor leukocyte transfusions and discontinuation of immunosuppressants to achieve an initial remission after allogeneic bone marrow transplantation in a patient with primary refractory acute leukemia.
Azuno Y; Kaneko T; Nishimura M; Okuya S; Nakai K; Nomiyama J; Mori K; Okafuji K; Okubo M; Matsutani A; Kamei S; Zaitsu Y; Takeuchi Y; Oka Y; Kaku K
Bone Marrow Transplant; 1996 Jul; 18(1):257-9. PubMed ID: 8832032
[TBL] [Abstract][Full Text] [Related]
93. [Minimal residual disease in chronic myelogenous leukemia].
Ogawa H
Nihon Rinsho; 2001 Dec; 59(12):2348-52. PubMed ID: 11766337
[TBL] [Abstract][Full Text] [Related]
94. Estimations of BCR-ABL/ABL transcripts by quantitative PCR in chronic myeloid leukaemia after allogeneic bone marrow transplantation and donor lymphocyte infusion.
Otazú IB; Tavares Rde C; Hassan R; Zalcberg I; Tabak DG; Seuánez HN
Leuk Res; 2002 Feb; 26(2):129-41. PubMed ID: 11755463
[TBL] [Abstract][Full Text] [Related]
95. Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trial.
Dombret H; Gabert J; Boiron JM; Rigal-Huguet F; Blaise D; Thomas X; Delannoy A; Buzyn A; Bilhou-Nabera C; Cayuela JM; Fenaux P; Bourhis JH; Fegueux N; Charrin C; Boucheix C; Lhéritier V; Espérou H; MacIntyre E; Vernant JP; Fière D;
Blood; 2002 Oct; 100(7):2357-66. PubMed ID: 12239143
[TBL] [Abstract][Full Text] [Related]
96. Successful prevention of hematological relapse for a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic bone marrow transplantation by donor leukocyte infusion.
Yazaki M; Andoh M; Ito T; Ohno T; Wada Y
Bone Marrow Transplant; 1997 Feb; 19(4):393-4. PubMed ID: 9051252
[TBL] [Abstract][Full Text] [Related]
97. Detection of bcr/abl mRNA in a case of chronic myelogenous leukemia in long-term remission: CML or sensitivity of detection?
Anguita E; Villegas A; Díaz-Mediavilla J; González FA; del Potro E; Espinós D
Haematologica; 1998 Aug; 83(8):744-7. PubMed ID: 9793259
[TBL] [Abstract][Full Text] [Related]
98. Ribozyme-mediated inhibition of a Philadelphia chromosome-positive acute lymphoblastic leukemia cell line expressing the p190 bcr-abl oncogene.
Snyder DS; Wu Y; McMahon R; Yu L; Rossi JJ; Forman SJ
Biol Blood Marrow Transplant; 1997 Oct; 3(4):179-86. PubMed ID: 9360779
[TBL] [Abstract][Full Text] [Related]
99. Comparison of genomic DNA and cDNA for detection of residual disease after treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation.
Zhang JG; Lin F; Chase A; Goldman JM; Cross NC
Blood; 1996 Mar; 87(6):2588-93. PubMed ID: 8630427
[TBL] [Abstract][Full Text] [Related]
100. G-CSF stimulation of donor myelopoiesis prolongs survival of relapsed BCR-ABL-positive acute lymphoblastic leukemia after allogeneic marrow transplantation.
Keil F; Kalhs P; Haas OA; Fritsch G; Lechner K; Mannhalter C; Greinix HT
Bone Marrow Transplant; 1996 Sep; 18(3):655-7. PubMed ID: 8879636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
